HLA-G and breast carcinoma: The correlation of unfavorable clinical outcomes with high expression of vesicle-bound soluble HLA-G (sHLA-G) and the presence of stem-cell like CTCs in patients with breast cancer after neo-adjuvant chemotherapy indicates that CTCs exploit sHLA-G to escape NK cell-mediated cytotoxicity [71].